TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia.

Authors :: Langenberg-Ververgaert K
Renzi S
Fuligni F
Davidson S
Abdelhaleem M
Lo W
Malkin D
Shlien A
Shago M
Villani A
Abla O
Source :: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Jan; Vol. 68 (1), pp. e28542. Date of Electronic Publication: 2020 Aug 02.
Publication Year :: 2021

Subjects :: Antineoplastic Combined Chemotherapy Protocols therapeutic use
Fatal Outcome
Female
Humans
Infant
Leukemia, Megakaryoblastic, Acute drug therapy
Leukemia, Megakaryoblastic, Acute genetics
Leukemia, Megakaryoblastic, Acute pathology
Oncogene Proteins, Fusion genetics
Polymorphism, Single Nucleotide
Promoter Regions, Genetic
RNA-Binding Proteins genetics
Telomerase genetics
Trans-Activators genetics

Full Text Access

Tools